Integra Therapeutics, empresa biotecnològica especialitzada en tecnologia de redacció genètica d’última generació, membre de Catalonia.health, ha anunciat el nomenament de Miles Gerson com a president independent del seu Consell d’Administració.

The biopharmaceutical company Reig Jofre, a member of Catalonia.health, has announced the consolidation of its stake in Leanbio, a biotechnology company specialising in the development and production of biotechnological active pharmaceutical ingredients and also a member of Catalonia.health. 

The biotechnology start-up Nuage Therapeutics, a member of Catalonia.health, has secured €2.7 million in funding from the Spanish State Research Agency (AEI) of the Ministry of Science, Innovation and Universities

The Josep Carreras Leukaemia Research Institute, a member of Catalonia.health, is leading a new international alliance to accelerate the development of innovative diagnostic tools and therapeutic strategies for follicular lymphoma, one of the most common blood cancers.

mjn-neuro, a start-up specialising in neurotechnology applied to digital health and a member of Catalonia.health, and the European pharmaceutical group Neuraxpharm have announced plans to launch EPISERAS®

GoodGut, a biotechnology company specialising indigestive health solutions based on the intestinal microbiota and a member of Catalonia.health, is participating in a study being carried out at four primary care centres in the Girona Health Region to improve the diagnosis of irritable bowel syndrome.

The biotechnology company HIPRA, a member of Catalonia.health, is part of a European consortium led by the Medical University of Vienna aimed at developing a next-generation intranasal influenza vaccine. 

Catalonia.health welcomed a visit this December from an institutional and business delegation from Malaysia's health sector, interested in gaining first-hand knowledge of the Catalan medtech ecosystem and the know-how of the country's health innovation companies and institutions.

Arantxa Sanz, CEO of Catalonia.health, participated in the European Health Summit in Brussels addressing how AI influences the interpretation of European health regulations. The study presented by LLYC reveals significant disparities in quality and access to information based on user profile and geography, emphasizing the need for reliable sources.

Catalonia.health has opened the call for its annual awards. The Catalan health ecosystem once again recognises the excellence of its members through awards that highlight innovation, collaboration and impact on health.

Catalonia.Health welcomes Marta Herrera as Head of Communications for the organisation. With this addition, we are strengthening our commitment to strategic communication in order to amplify the visibility and projection of the association's leadership, equipping ourselves with the capabilities to empower our community and ensure the impact of the valuable actions we generate together.

The technology centre Eurecat, a member of Catalonia.health, has received the IX National Congress of Entrepreneurial Scientists award for the development of a 3D-printed vascular stent.

The biotechnology company SpliceBio, a member of Catalonia.Health, has been selected as a finalist in several leading international awards in the life sciences sector. 

The life science venture capital Asabys, a member of Catalonia.health, has co-led a €37 million funding round for Qida, a provider of home-basedservices and products for senior well-being.

The pharmaceutical company Mitelos, a member of Catalonia.health, announced an exclusive licensing and distribution agreement with East Midlands Pharma (EM Pharma), a leading UK distributor of consumer health and OTC medical products.

The biopharmaceutical company ORYZON, a member of Catalonia.health, has announced that the first patient has been enrolled in RESTORE, its multi‑center,open‑label Phase Ib clinical trial of iadademstat in adults with sickle cell disease (SCD). 

Abzu, a member of Catalonia.health, and ADViRNA, a boutique U.S.-based CRO, are joining forces to develop novel siRNA therapeutics.

The venture capital company Asabys Partners, a member of Catalonia.health, and AltamarCAM  Partners, a global investment firm specialized in private markets, have reached an agreement to integrate Aliath Bioventures, a member of Catalonia.health, the life sciences team, into Asabys and to co-manage the Alta Life Sciences Spain I FCR fund.

The packaging company Miton, a member of Catalonia.health, has obtained international B Corp certification, a recognition that distinguishes companies that meet the highest standards of sustainability, social responsibility, and transparency, and that use business as a force for positive impact on society and the environment.

Vall  d'Hebron Research Institute (VHIR), a member of Catalonia.health, and Prous Institute for Biomedical Research have signed a three-year collaboration agreement to promote high-impact research projects that form part of or are in the selection phase of the VHIR's innovation portfolio.